aod9604 phase 2b trial results weight loss AOD 9604 vs. Semaglutide AOD 9604 with tirzepatide: the

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

How AOD-9604 Supports Weight Loss AOD-9604 works by mimicking the fat-burning effects of growth hormone without its other metabolic impacts

Differences in rate of absorption may become important for drugs given as a single dose, such as a hypnotic used to induce sleep

ThinWorks reviews your results and builds a schedule around your body instead of a one-size-fits-all plan